Our Products
At Pharmotechs, our unique approach opens pathways to a broad range of meticulously selected products across various therapeutic domains. Our product line is in a constant state of evolution, expanding continuously as we dedicate ourselves to improving and delivering the most efficient solutions to the market.
One particularly noteworthy area of innovation lies within biopharmaceuticals, where Ireland has emerged as a global frontrunner. we are driving forward groundbreaking biologic therapies, leveraging the capabilities of living organisms to address a diverse array of ailments, from cancer and autoimmune diseases to rare genetic disorders.
Pharmotech’s Patient Safety team consists of skilled medical and scientific experts specialized in pharmacovigilance (PV). They rigorously monitor and evaluate the safety of our products across their lifecycle, utilizing risk mitigation strategies to enhance their benefit-risk profile. With thorough signal and risk management processes, bolstered by Irish & European safety governance framework, Pharmotech promptly assesses new safety data to gauge its impact on patients.
We adhere to EU WDA regulations and GDP guidelines in trading our products, ensuring compliance with regulations as we manage, mitigate, and communicate risks to healthcare providers and patients globally.
